Trends in the prognosis of patients with primary metastatic breast cancer diagnosed between 1975 and 2002

被引:36
作者
Ernst, Miranda F. [2 ,3 ]
van de Poll-Franse, Lonneke V.
Roukema, Jan A. [3 ]
Coebergh, Jan Willem W. [4 ]
van Gestel, Cornelia M. J. [3 ]
Vreugdenhil, Gerard [5 ]
Louwman, Marieke J. [4 ]
Voogd, Adri C. [1 ,4 ]
机构
[1] Maastricht Univ, Dept Epidemiol, Maastricht, Netherlands
[2] Jeroen Bosch Hosp, Dept Surg, Shertogenbosch, Netherlands
[3] St Elizabeth Hosp, Dept Surg, Tilburg, Netherlands
[4] Comprehens Canc Ctr S, Eindhoven, Netherlands
[5] Maxima Med Ctr, Dept Med Oncol, Veldhoven, Netherlands
关键词
breast carcinoma; neoplasm metastasis; trends; prognosis; survival rate;
D O I
10.1016/j.breast.2007.01.001
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
We performed a population-based study, including 1089 patients with primary metastatic breast cancer, diagnosed in South-East Netherlands between 1975 and 2002, and tried to give an answer to the question if prognosis of this patient group has improved or not. Follow-up was completed until 1 January 2005. The median survival times for patients with primary metastatic disease were 18, 17 and 20.5 months for patients diagnosed in the periods 1975-1984, 1985-1994 and 1995-2002, respectively. A multivariate analysis, including age, tumour size and information on the localization of metastatic disease and the number of metastatic sites, showed that patients diagnosed in the period 1995-2002 had a 18% tower death risk (95% confidence interval 5-30) compared to those diagnosed in the period 1985-1994. These data show that the prognosis of patients with primary metastatic breast cancer remained unchanged between 1975 and 1994 and that some progress has been made after 1994. (C) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:344 / 351
页数:8
相关论文
共 20 条
[1]
Breast cancer with synchronous metastases: Trends in survival during a 14-year period [J].
Andre, F ;
Slimane, K ;
Bachelot, T ;
Dunant, A ;
Namer, M ;
Barrelier, A ;
Kabbaj, O ;
Spano, JP ;
Marsiglia, H ;
Rouzier, R ;
Delaloge, S ;
Spielmann, M .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (16) :3302-3308
[2]
[Anonymous], 1975, SEER CANC STAT REV
[4]
COEBERGH JW, 2001, CANC INCIDENCE CARE, P29
[5]
The process of metastasisation for breast cancer [J].
Engel, J ;
Eckel, R ;
Kerr, J ;
Schmidt, M ;
Fürstenberger, G ;
Richter, R ;
Sauer, H ;
Senn, HJ ;
Hölzel, D .
EUROPEAN JOURNAL OF CANCER, 2003, 39 (12) :1794-1806
[6]
Breast carcinoma diagnosis, treatment, and prognosis before and after the introduction of mass mammographic screening [J].
Ernst, MF ;
Voogd, AC ;
Coebergh, JWW ;
Roukema, JA .
CANCER, 2004, 100 (07) :1337-1344
[7]
Perioperative screening for metastatic disease is not indicated in patients with primary breast cancer and no clinical signs of tumor spread [J].
Gerber, B ;
Seitz, E ;
Müller, H ;
Krause, A ;
Reimer, T ;
Kundt, G ;
Friese, K .
BREAST CANCER RESEARCH AND TREATMENT, 2003, 82 (01) :29-37
[8]
A COMPUTER-PROGRAM PACKAGE FOR RELATIVE SURVIVAL ANALYSIS [J].
HAKULINEN, T ;
ABEYWICKRAMA, KH .
COMPUTER PROGRAMS IN BIOMEDICINE, 1985, 19 (2-3) :197-207
[9]
HERMANEK P, 1987, UICC TNM CLASSIFICAT, P94
[10]
IMPROVED PROGNOSIS OF BREAST-CANCER SINCE 1970 IN SOUTH-EASTERN NETHERLANDS [J].
NAB, HW ;
HOP, WCJ ;
CROMMELIN, MA ;
KLUCK, HM ;
COEBERGH, JWW .
BRITISH JOURNAL OF CANCER, 1994, 70 (02) :285-288